G-CSF was associated with a statistically significant 44% reduction in the incidence of severe neutropenia (relative risk 0.56, P<0.001) and a 43% reduction in the number of patients with a clinically relevant infection (relative risk 0.57, P<0.001). This evidence concerns the gene CSF3 and infection.